Annual report [Section 13 and 15(d), not S-K Item 405]

Stock-Based Compensation - Additional Information (Details)

v3.26.1
Stock-Based Compensation - Additional Information (Details) - USD ($)
 1 Months Ended 12 Months Ended
Feb. 21, 2026
Jan. 01, 2026
Feb. 28, 2025
Dec. 31, 2025
Dec. 31, 2024
Jan. 03, 2025
Oct. 09, 2024
Jun. 07, 2024
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Total stock-based compensation expense       $ 15,309,924 $ 8,140,617      
Common stock shares reserved for issuance       6,751,636   27,453,993    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value       $ 7,700,000        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value       $ 5,700,000        
Options, Grants in Period, Weighted Average Fair Value       $ 1.85 $ 0.62      
Fair Values of Stock Options, Vested, Total       $ 6,865,815 $ 7,863,021      
Total incremental fair value expense recognized             $ 200,000  
Number of options vest purchase       0        
2020 Equity Incentive Plan [Member]                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Number of shares available for grant           23,895,769    
Plan modification       . On June 27, 2025, the stockholders approved an amendment to the 2020 Plan, pursuant to which an automatic evergreen provision was added to provide for an annual increase in January to the number of shares available for issuance under the 2020 Plan and to extend the term of such plan by approximately five years to 2030        
Restricted Stock Units [Member]                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Restricted stock units outstanding       0 0      
CorHepta Pharmaceuticals [Member] | Restricted Stock [Member]                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Restricted share issued     1,660,222          
Service based vesting shares     996,133          
Performance based vesting shares     166,023          
Service and performance based vesting shares     498,066          
Fair Value Of Restricted Stock Granted       $ 4,900,000        
Total stock-based compensation expense       2,500,000        
Unrecognized Compensation Cost       $ 2,400,000        
Subsequent Event | 2020 Equity Incentive Plan [Member]                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Number of additional shares authorized   6,969,206            
Subsequent Event | Restricted Stock [Member]                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Number of Shares, Forfeited 498,066              
Performance Based forfeited Shares 166,023              
2020 Plan                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Common stock shares reserved for issuance           27,453,993   2,500,000
2011 Plan and 2020 Plan                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Number of Shares, Forfeited       7,614,521 1,140,595      
Unrecognized stock-based compensation of unvested options       $ 43,563,066        
Number of options vest purchase       30,100,872 17,219,692      
Expected to Recognize, Remaining Weighted-Average Period       3 years 1 month 13 days